Drug-induced hair colour changes

被引:26
作者
Ricci, Francesco [1 ]
De Simone, Clara [1 ]
Del Regno, Laura [1 ]
Peris, Ketty [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Inst Dermatol, Rome, Italy
关键词
hair colour changes; hair depigmentation; hair hyperpigmentation; drug; TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; RENAL-CELL CARCINOMA; MESYLATE CAUSES HYPOPIGMENTATION; VITILIGO-LIKE LESIONS; IMATINIB MESYLATE; SKIN HYPOPIGMENTATION; BLOCKING ANTIBODIES; PIGMENTARY CHANGES; PEDIATRIC-PATIENT;
D O I
10.1684/ejd.2016.2844
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Hair colour modifications comprise lightening/greying, darkening, or even a complete hair colour change, which may involve the scalp and/or all body hair. Systemic medications may cause hair loss or hypertrichosis, while hair colour change is an uncommon adverse effect. The rapidly increasing use of new target therapies will make the observation of these side effects more frequent. A clear relationship between drug intake and hair colour modification may be difficult to demonstrate and the underlying mechanisms of hair changes are often unknown. To assess whether a side effect is determined by a specific drug, different algorithms or scores (e.g. Naranjo, Karch, Kramer, and Begaud) have been developed. The knowledge of previous similar reports on drug reactions is a key point of most algorithms, therefore all adverse events should be recognised and reported to the scientific community. Furthermore, even if hair colour change is not a life-threatening side effect, it is of deep concern for patient's quality of life and adherence to treatment. We performed a review of the literature on systemic drugs which may induce changes in hair colour.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 50 条
  • [1] Drug-induced hair colour changes
    Francesco Ricci
    Clara De Simone
    Laura Del Regno
    Ketty Peris
    European Journal of Dermatology, 2016, 26 : 531 - 536
  • [2] An Update on Drug-Induced Pigmentation
    Nahhas, Amanda F.
    Braunberger, Taylor L.
    Hamzavi, Iltefat H.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2019, 20 (01) : 75 - 96
  • [3] Chemotherapeutic drug-induced nail changes: A prospective observational study
    Samal, Kallolinee
    Mohanty, Srigopal
    Satapathy, Smaranika
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2021, 15 (03): : 61 - 65
  • [4] Drug-induced pruritus
    Maleki, K.
    Weisshaar, E.
    HAUTARZT, 2014, 65 (05): : 436 - 442
  • [5] Drug-Induced Enteropathy
    Marietta, Eric V.
    Cartee, Amanda
    Rishi, Abdul
    Murray, Joseph A.
    DIGESTIVE DISEASES, 2015, 33 (02) : 215 - 220
  • [6] Drug-induced immunotoxicity
    P. M. Dansette
    E. Bonierbale
    C. Minoletti
    P. H. Beaune
    D. Pessayre
    D. Mansuy
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 443 - 451
  • [7] Drug-induced immunotoxicity
    Dansette, PM
    Bonierbale, E
    Minoletti, C
    Beaune, PH
    Pessayre, D
    Mansuy, D
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (04) : 443 - 451
  • [8] Drug-Induced Gynecomastia
    Bowman, John D.
    Kim, Hyunah
    Bustamante, Juan J.
    PHARMACOTHERAPY, 2012, 32 (12): : 1123 - 1140
  • [9] DRUG-INDUCED HYPERTENSION
    LAI, KN
    RICHARDS, AM
    NICHOLLS, MG
    ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1991, 10 (01) : 31 - 46
  • [10] Drug-induced shock
    Liebhart, Jerzy
    Panaszek, Bernard
    PHARMACOLOGICAL REPORTS, 2007, 59 : 99 - 103